Increased circulating concentrations of IL-36γ found in obesity have been proposed as a protective mechanism due to their negative association with glucose and hemoglobin A1c levels among patients with T2D (17). This evidence concerns the gene IL36G and obesity due to melanocortin 4 receptor deficiency.